• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE SENSOR; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE SENSOR; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 101967-950
Device Problem Imprecision (1307)
Patient Problem Hyperglycemia (1905)
Event Date 05/21/2023
Event Type  Injury  
Manufacturer Narrative
This report is being submitted retrospectively as part of internal review.The investigation was performed on the user synced glucose data on data management system (dms), which is an eversense cloud platform.The dms investigation analysis could not confirm the adverse event because the sensor was already retired and the system was not in use at the time of incident.The system asserted an early sensor replacement alert on (b)(6) 2023 at 10:58 am after 147 days of use.Due to early sensor retirement, a return material authorization (rma) was issued to bring back the sensor for further investigation and to determine the root cause.The returned sensor was investigated which revealed a loss of chemical performance.The eversense cgm system correctly disabled the sensor due to performance failure indicated by metric of sensor performance (msp) value going below the established threshold.The system's self test functions worked as expected by retiring the sensor.The root cause of such failure is due to the oxidation of sensor's hydrogel.No further investigation was found necessary for this complaint.
 
Event Description
Senseonics was made aware of an incident where the customer experienced a hyperglycemic event on (b)(6) 2023, after the sensor retired prematurely.The sensor retired a day before on (b)(6) 2023.There was no sensor glucose readings because of the early sensor retirement.The blood glucose (bg) value at the time of incident was 298 mg/dl.The customer did not seek any medical treatment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE SENSOR
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key18117333
MDR Text Key327888388
Report Number3009862700-2023-00271
Device Sequence Number1
Product Code QHJ
Combination Product (y/n)Y
Reporter Country CodeGM
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 11/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/12/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date06/16/2023
Device Model Number101967-950
Device Catalogue NumberFG-4500-50-302
Device Lot Number6.04.04W
Was Device Available for Evaluation? No
Date Manufacturer Received08/18/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/30/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-